Cohlhepp Ryan

CIK 00020346651 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002034665

Recent Transactions

50 trades

Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-09-08$3.79/sh+17,500→ 199,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-09-08−17,500→ 34,252 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-09-08$23.43/sh−3,442→ 181,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-09-08$22.77/sh−14,058→ 185,083 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-08-10−18,750→ 51,752 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-08-10$3.79/sh+18,750→ 200,391 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-08-10$27.98/sh−18,750→ 181,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-07-09$29.00/sh−536→ 181,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-07-08$30.35/sh−1,075→ 182,177 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-07-08−18,750→ 70,502 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-07-08$3.79/sh+18,750→ 210,391 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-07-08$28.76/sh−22,833→ 187,558 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-07-08$29.80/sh−4,306→ 183,252 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-05-15$3.79/sh+8,000→ 204,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-05-15−8,000→ 101,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-05-15$20.29/sh−4,500→ 191,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-05-15$20.29/sh−8,000→ 196,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-04-15−8,000→ 109,334 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-04-15$3.79/sh+8,000→ 208,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-04-15$23.01/sh−8,000→ 200,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-04-15$23.01/sh−4,500→ 196,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-16−8,000→ 117,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-16$19.66/sh−4,500→ 200,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-16$19.66/sh−8,000→ 205,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-16$3.79/sh+8,000→ 213,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$3.79/sh+12,892→ 222,533 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-03−12,892→ 125,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$18.16/sh−12,892→ 209,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$18.16/sh−4,500→ 205,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-02-25$3.79/sh+3,108→ 213,272 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-02-25$18.04/sh−3,108→ 210,164 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-02-25$18.04/sh−523→ 209,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-25−3,108→ 138,226 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-02+300,000→ 300,000 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-22$18.10/sh−3,828→ 210,164 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-15$18.02/sh−149→ 213,992 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-12-26−25,000→ 39,909 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-26$4.44/sh+25,000→ 214,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$18.68/sh−4,500→ 189,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$3.79/sh+8,000→ 201,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$18.68/sh−8,000→ 193,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-12-15−8,000→ 141,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$18.05/sh−4,500→ 193,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$3.79/sh+8,000→ 206,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$18.05/sh−8,000→ 198,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-21−8,000→ 149,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$18.16/sh−8,000→ 202,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-15−8,000→ 157,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$18.16/sh−4,500→ 198,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$3.79/sh+8,000→ 210,641 total

Companies

Bicara Therapeutics Inc.
Director, President, COO & Interim CEO
$BCAX

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov